AbbVie Return On Equity from 2010 to 2025

ABBV Stock  USD 201.34  7.83  3.74%   
AbbVie Return On Equity yearly trend continues to be fairly stable with very little volatility. Return On Equity will likely drop to 0.70 in 2025. Return On Equity is a measure of the profitability of AbbVie Inc in relation to the equity, calculated by dividing net income by shareholder's equity. View All Fundamentals
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
1.28661654
Current Value
0.7
Quarterly Volatility
0.69331734
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.8 B, Interest Expense of 2.9 B or Selling General Administrative of 8.3 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 99.06. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Return On Equity Growth Pattern

Below is the plot of the Return On Equity of AbbVie Inc over the last few years. Return on Equity is the amount of AbbVie Inc net income returned as a percentage of AbbVie equity. Return on equity measures AbbVie profitability by revealing how much profit AbbVie Inc generates with the money shareholders have invested. It is a measure of the profitability of a business in relation to the equity, calculated by dividing net income by shareholder's equity. AbbVie's Return On Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.6210 Years Trend
Very volatile
   Return On Equity   
       Timeline  

AbbVie Return On Equity Regression Statistics

Arithmetic Mean0.64
Geometric Mean0.75
Coefficient Of Variation107.75
Mean Deviation0.52
Median0.75
Standard Deviation0.69
Sample Variance0.48
Range2.5331
R-Value(0.1)
Mean Square Error0.51
R-Squared0.01
Significance0.72
Slope(0.01)
Total Sum of Squares7.21

AbbVie Return On Equity History

2025 0.7
2024 1.29
2023 0.47
2022 0.69
2021 0.75
2020 0.35
2019 -0.96

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Return On Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Equity 1.29  0.70 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.